IL83121A - 3-beta-(disubstituted succinimido)azetidinones,useful as beta-lactam intermediates and their preparation - Google Patents

3-beta-(disubstituted succinimido)azetidinones,useful as beta-lactam intermediates and their preparation

Info

Publication number
IL83121A
IL83121A IL83121A IL8312187A IL83121A IL 83121 A IL83121 A IL 83121A IL 83121 A IL83121 A IL 83121A IL 8312187 A IL8312187 A IL 8312187A IL 83121 A IL83121 A IL 83121A
Authority
IL
Israel
Prior art keywords
beta
disubstituted
azetidinones
succinimido
useful
Prior art date
Application number
IL83121A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL83121A publication Critical patent/IL83121A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
IL83121A 1986-07-10 1987-07-08 3-beta-(disubstituted succinimido)azetidinones,useful as beta-lactam intermediates and their preparation IL83121A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/884,124 US4734498A (en) 1986-07-10 1986-07-10 3β-succinimidoazetidinones as chiral intermediates

Publications (1)

Publication Number Publication Date
IL83121A true IL83121A (en) 1992-09-06

Family

ID=25384007

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83121A IL83121A (en) 1986-07-10 1987-07-08 3-beta-(disubstituted succinimido)azetidinones,useful as beta-lactam intermediates and their preparation

Country Status (11)

Country Link
US (1) US4734498A (xx)
EP (1) EP0252744B1 (xx)
JP (1) JP2510600B2 (xx)
KR (1) KR950013767B1 (xx)
AT (1) ATE98644T1 (xx)
CA (1) CA1320209C (xx)
DE (1) DE3788463T2 (xx)
ES (1) ES2061503T3 (xx)
HU (1) HU197896B (xx)
IE (1) IE61494B1 (xx)
IL (1) IL83121A (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0715235Y2 (ja) * 1989-01-31 1995-04-10 鐘淵化学工業株式会社 画像読み取り装置に於けるセンサ素子の位置決め装置
DK0479431T3 (da) * 1990-09-13 2000-03-27 Lilly Co Eli Mellemprodukter for 1-carbacephalosporiner og fremgangsmåde til fremstilling heraf
US5225553A (en) * 1990-09-13 1993-07-06 Eli Lilly And Company Intermediates to 1-carbacephalosporins and process for preparation thereof
US5159073A (en) * 1990-09-13 1992-10-27 Eli Lilly And Company Intermediates to 1-carbacephalosporins and process for preparation thereof
US5175256A (en) * 1990-09-28 1992-12-29 Neorx Corporation Protein labeling reagents
US5599336A (en) * 1992-07-02 1997-02-04 The Procter & Gamble Company Absorbent hydrogel fines in absorbent structures
JP4212112B2 (ja) 1996-02-23 2009-01-21 イーライ・リリー・アンド・カンパニー 非ペプチジルバソプレッシンV1aアンタゴニスト
JP2000247934A (ja) * 1999-02-23 2000-09-12 Toray Ind Inc 高光学純度アミノ酸ベンジルエステルの製造法
US6706916B1 (en) 1999-02-23 2004-03-16 Toray Fine Chemicals Co., Ltd. Optically active amino acid derivatives and processes for the preparation of the same
JP4524841B2 (ja) * 1999-03-02 2010-08-18 東レ・ファインケミカル株式会社 光学活性アミノ酸エステル酒石酸アミドおよびその製造法
CN105712985A (zh) * 2001-10-12 2016-06-29 阿泽范药品公司 β-内酰胺后叶加压素V1a拮抗剂
US9597314B2 (en) 2005-03-22 2017-03-21 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids for treating premenstrual disorders
AU2006270039B2 (en) 2005-07-19 2013-07-04 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
US20100016274A1 (en) * 2006-09-14 2010-01-21 Koppel Gary A Beta-lactam cannabinoid receptor modulators
KR100932221B1 (ko) * 2007-11-07 2009-12-16 강원대학교산학협력단 베타락탐 올리고머 및 이의 제조방법
CN103269584B (zh) 2010-07-01 2017-05-03 阿泽凡药物公司 用于治疗创伤后应激障碍的方法
MX2016012645A (es) 2014-03-28 2017-01-11 Azevan Pharmaceuticals Inc Composiciones y metodos para tratar enfermedades neurodegenerativas.
WO2019055913A1 (en) 2017-09-15 2019-03-21 Azevan Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF BRAIN INJURY

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665171A (en) * 1985-07-17 1987-05-12 Harvard University Process and intermediates for β-lactam antibiotics

Also Published As

Publication number Publication date
ES2061503T3 (es) 1994-12-16
DE3788463T2 (de) 1994-04-28
DE3788463D1 (de) 1994-01-27
EP0252744A3 (en) 1989-12-13
JPS6323858A (ja) 1988-02-01
ATE98644T1 (de) 1994-01-15
HUT44536A (en) 1988-03-28
EP0252744B1 (en) 1993-12-15
US4734498A (en) 1988-03-29
KR880001638A (ko) 1988-04-25
EP0252744A2 (en) 1988-01-13
JP2510600B2 (ja) 1996-06-26
KR950013767B1 (ko) 1995-11-15
HU197896B (en) 1989-06-28
IE61494B1 (en) 1994-11-02
CA1320209C (en) 1993-07-13
IE871841L (en) 1988-01-10

Similar Documents

Publication Publication Date Title
IL83121A (en) 3-beta-(disubstituted succinimido)azetidinones,useful as beta-lactam intermediates and their preparation
EP0232042A3 (en) Cast or ductile iron inoculant
IE851917L (en) Hydroxylamine derivatives, azetidinones and process for¹preparing azetidinones
DE3587546D1 (de) Verfahren zur Herstellung von optisch aktiven Acyloxyazetidinonen.
ATE86644T1 (de) Pigmentzusammensetzung.
HUT45048A (en) Process for producing azetidinone derivative intermediary product of antibiotics
ATE62224T1 (de) Verfahren zur herstellung von azetidinonzwischenprodukten.
ATE111086T1 (de) N-(substituiertes-1-piperazinalkyl)-alpha-(3,5- dialkyl-4-hydroxyphenyl)-alpha,alpha- dialkylacetamide.
GR3005189T3 (xx)
GR3026388T3 (en) Novel 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA
AU621749B2 (en) Process for synthesizing beta-lactam compounds
DE69427100T2 (de) Herstellung von Beta-lactamverbindungen und Zwischenprodukte
DE69422386T2 (de) Cyclopropyl-derivate, verfahren zur herstellung und anwendungen
IL91932A0 (en) Azetidinone intermediates to carbacephalosporins and process
ES2017537B3 (es) Acidos 1,3,4,9-tetrahidropizano [3,4-b] indol-1-aceticos sustituidos.
ATE109771T1 (de) Verfahren zur herstellung von azetidinonen.
EP0259987A3 (en) Amino acid derivatives and their production and use in preparing carbapenem and carbapenam compounds
FI923615A (fi) Substituoituja N3-tioasyylisemikarbatsideja

Legal Events

Date Code Title Description
KB Patent renewed